skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients

Caocci, Giovanni ; Martino, Bruno ; Greco, Marianna ; Abruzzese, Elisabetta ; Trawinska, Malgorzata Monika ; Lai, Sara ; Ragatzu, Paola ; Galimberti, Sara ; Baratè, Claudia ; Mulas, Olga ; Labate, Claudia ; Littera, Roberto ; Carcassi, Carlo ; Passerini, Carlo Gambacorti ; La Nasa, Giorgio

Experimental hematology, 2015-12, Vol.43 (12), p.1015-1018.e1 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

Kreutzman, Anna ; Jaatinen, Taina ; Greco, Dario ; Vakkila, Emmi ; Richter, Johan ; Ekblom, Marja ; Hjorth-Hansen, Henrik ; Stenke, Leif ; Melo, Teresa ; Paquette, Ron ; Seggewiss-Bernhardt, Ruth ; Guerci-Bresler, Agnés ; Talbot, Alexis ; Cayuela, Jean Michel ; Mahon, Francois-Xavier ; Porkka, Kimmo ; Lipton, Jeff ; Partanen, Jukka ; Rousselot, Philippe ; Mustjoki, Satu

Experimental hematology, 2012-11, Vol.40 (11), p.906-913.e1 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por
3
What do kinase inhibition profiles tell us about tyrosine kinase inhibitors used for the treatment of CML?
What do kinase inhibition profiles tell us about tyrosine kinase inhibitors used for the treatment of CML?
Material Type:
Artigo 		Adicionar ao Meu Espaço

What do kinase inhibition profiles tell us about tyrosine kinase inhibitors used for the treatment of CML?

Deininger, Michael W ; Manley, Paul

Leukemia research, 2012-03, Vol.36 (3), p.253-261 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Irreversible sensorineural hearing loss due to Imatinib
Irreversible sensorineural hearing loss due to Imatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Irreversible sensorineural hearing loss due to Imatinib

Attili, Venkata Satya Suresh ; Bapsy, P.P ; Anupama, G ; Lokanatha, D

Leukemia research, 2008-06, Vol.32 (6), p.991-992 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib
Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib

Sawadogo, Salifo ; Hien, Francis Michel ; Ouédraogo, Macaire Sampawendé ; Drabo, Youssouf Joseph

The Pan African medical journal, 2014, Vol.18, p.142-142 [Periódico revisado por pares]

Uganda

Texto completo disponível

Citações Citado por
6
Particular evolution of complex cytogenetic variants of chronic myeloid leukemia treated with imatinib
Particular evolution of complex cytogenetic variants of chronic myeloid leukemia treated with imatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Particular evolution of complex cytogenetic variants of chronic myeloid leukemia treated with imatinib

Sawadogo, Salifo ; Hien, Francis Michel ; Béogo, Rasmané ; Toguyeni, Aboubacar ; Ouédraogo, Georges Anicet

The Pan African medical journal, 2013, Vol.15, p.132 [Periódico revisado por pares]

Uganda

Texto completo disponível

Citações Citado por
7
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities

Pawarode, Attaphol ; Sait, Sheila N.J ; Nganga, Alain ; Coignet, Lionel J ; Barcos, Maurice ; Baer, Maria R

Leukemia research, 2007-11, Vol.31 (11), p.1589-1592 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Treatment of chronic myeloid leukemia with imatinib. A case of translational medicine
Treatment of chronic myeloid leukemia with imatinib. A case of translational medicine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of chronic myeloid leukemia with imatinib. A case of translational medicine

Dosne Pasqualini, Christiane

Medicina (Buenos Aires), 2010, Vol.70 (3), p.293-296 [Periódico revisado por pares]

Argentina

Texto completo disponível

Citações Citado por
9
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Material Type:
Artigo 		Adicionar ao Meu Espaço

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

Bower, Hannah ; Björkholm, Magnus ; Dickman, Paul W ; Höglund, Martin ; Lambert, Paul C ; Andersson, Therese M-L

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2851-2857 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

Cortes, Jorge E ; Gambacorti-Passerini, Carlo ; Deininger, Michael W ; Mauro, Michael J ; Chuah, Charles ; Kim, Dong-Wook ; Dyagil, Irina ; Glushko, Nataliia ; Milojkovic, Dragana ; le Coutre, Philipp ; Garcia-Gutierrez, Valentin ; Reilly, Laurence ; Jeynes-Ellis, Allison ; Leip, Eric ; Bardy-Bouxin, Nathalie ; Hochhaus, Andreas ; Brümmendorf, Tim H

Journal of clinical oncology, 2018-01, Vol.36 (3), p.231-237 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.097)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.196)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (16)
  2. 1996Até2002  (29)
  3. 2003Até2009  (283)
  4. 2010Até2017  (648)
  5. Após 2017  (222)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.188)
  2. Japonês  (157)
  3. Português  (17)
  4. Espanhol  (5)
  5. Polonês  (3)
  6. Francês  (2)
  7. Serbian  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.